The group's principal activity is to provide venture capital management services. The group provides investment in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.. The group was founded in 1997. The group operates from the United States.
